SCHEDULE: Vanguard Group Reports Zero Insulet Corp Stake

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership of Insulet Corp common stock following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 14 to Schedule 13G regarding Insulet Corp common stock.
• The filing indicates that The Vanguard Group now beneficially owns 0 shares, representing 0% of Insulet Corp's common stock.
• This change is due to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such disaggregated subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, procedural filing. It reflects an internal reporting change by The Vanguard Group and does not convey positive or negative sentiment regarding Insulet Corp's operational or financial performance.

Future Outlook

No forward-looking statements or guidance regarding Insulet Corp's operations or financial performance are provided in this filing. The filing pertains solely to a change in beneficial ownership reporting by The Vanguard Group.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment.
• Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on SEC Release No. 34-39538.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine for large institutional investors like The Vanguard Group, especially when their beneficial ownership crosses certain thresholds or changes due to internal restructuring. This particular amendment clarifies a disaggregation of reporting, which is a common practice for large asset managers to comply with SEC regulations and accurately reflect their holdings across various funds and entities.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure for institutional investors and does not contain performance metrics for Insulet Corp that would allow for a direct comparison to industry standards or specific comparable companies.
• The change in reporting by The Vanguard Group is an internal operational and compliance matter, not directly related to Insulet Corp's business performance or industry benchmarks.

Corporate Governance

Stakeholder Impact

• Shareholders of Insulet Corp: Minimal direct impact, as the change reflects a reporting adjustment by a large institutional investor rather than a fundamental shift in Insulet's operations or value. It clarifies Vanguard's current non-holding status.
• The Vanguard Group: Impacts internal reporting and compliance procedures, ensuring adherence to SEC guidelines for disaggregated beneficial ownership.

Next Steps

• The Vanguard Group's subsidiaries and/or business divisions will continue to report their beneficial ownership separately on a disaggregated basis.

Key Dates

Keywords

Insulet Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Adviser, Ownership Change, Corporate Governance